BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Anand Rathi Report
Ami Organics Ltd. is an research and development driven manufacturer of speciality chemicals focused on two business segments, mainly pharmaceuticals advance intermediates also known as pharma intermediates and specialty chemicals.
Under pharma intermediates, it manufactures active pharmaceuticals ingredients and new chemical entities. It has developed and commercialised over 450 pharma intermediates for APIs across all 17 therapeutic areas and for new chemical entities.
Under its speciality chemical segment, Ami Organics manufactures key starting raw materials for agrochemicals and fine chemicals companies.
It has recently acquired two facilities from Gujarat Organics Ltd., which help to foray into preservatives and other specialty chemicals used in manufacturing of cosmetics, dye, polymers and agrochemicals.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR